Skip to Content
Find More Like This
Return to Search

Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma

United States Patent

September 30, 2014
View the Complete Patent at the US Patent & Trademark Office
Lawrence Berkeley National Laboratory - Visit the Technology Transfer and Intellectual Property Management Department Website
A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression.
Desprez; Pierre-Yves (Richmond, CA), Campisi; Judith (Berkeley, CA)
The Regents of the University of California (Oakland, CA), California Pacific Medical Center Research Institute (San Francisco, CA)
12/ 326,832
December 2, 2008
STATEMENT OF GOVERNMENTAL SUPPORT This invention was made with government support under Contract No. DE-AC03-76SF00098, now Contract No. DE-AC02-05CH11231, awarded by the United States Department of Energy, and under NIH Grant for NCI RO1CA82548. The Government has certain rights in this invention.